FDA-Device2020-08-26Class II
Chembio DPP COVID-19 IgM/IgG System- Rrapid immunochromatographic test for the qualitative detection and differentiation of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to SARS-CoV-2 in fingerstick whole blood, venous whole blood, serum, or plasma (lithium heparin or EDTA. Model Number: 65-9569-0
Chembio Diagnostics, Inc
Hazard
FDA revocation of the Emergency Use Authorization due to performance issues
Sold states
Nationwide
Affected count
7,674 kits (153,480 devices)
Manufactured in
3661 Horseblock Rd, N/A, Medford, NY, United States
Products
Chembio DPP COVID-19 IgM/IgG System- Rrapid immunochromatographic test for the qualitative detection and differentiation of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to SARS-CoV-2 in fingerstick whole blood, venous whole blood, serum, or plasma (lithium heparin or EDTA. Model Number: 65-9569-0
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2807-2020Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief